Metraipolis › archive › dc_49fc70d80bc9

RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation — Europe PMC PMID:41869446

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41869446
DOI
10.7150/jca.125407
License (as archived)
solo-consultazione
Archived
2026-11-06T09:48:29.938Z
SHA-256 of the archived text
520701e4666e06cadb61f0b5f068072607c1c30ac78704e6320d3cce4fb2b3aa
Stable URL of this page
https://metraipolis.com/documento/dc_49fc70d80bc9

How to cite

RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation — Europe PMC PMID:41869446 — Europe PMC (en), https://europepmc.org/article/MED/41869446 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49fc70d80bc9 (Metraipolis archive dc_49fc70d80bc9, sha256 520701e4666e06cadb61f0b5f068072607c1c30ac78704e6320d3cce4fb2b3aa)
BibTeX
@misc{dc49fc70d80bc9,
  title = {RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation — Europe PMC PMID:41869446},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41869446},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49fc70d80bc9; sha256 520701e4666e06cadb61f0b5f068072607c1c30ac78704e6320d3cce4fb2b3aa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869446. Agents can read the archived copy with the MCP tool read_document.